GINA 2024 Asthma Update: Revised Recommendations on …
Jun 28, 2024 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
GOLD COPD Report 2025: Key Spirometry and Drug Updates
Nov 22, 2024 · The 2025 GOLD COPD report, titled “Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report,” can now be downloaded from the GOLD website, along with a pocket guide to the report and the “2025 …
Air Embolism | Diagnosis & Disease Information - Pulmonology …
Apr 29, 2024 · Air embolism is a rare but potentially life-threatening medical condition that occurs when air bubbles enter the bloodstream, which can block the flow of blood to vital organs. 1,2 When an air bubble enters a vein, it is referred to as a venous air embolism, while an air bubble entering an artery is an arterial air embolism. 1 Epidemiology and Etiology of Air Embolism
Restrictive Lung Diseases | Diagnosis & Disease Information
May 29, 2024 · Restrictive lung diseases are respiratory disorders marked by diminished lung capacity stemming from a wide range of underlying factors, including changes in lung parenchyma or conditions that affect the pleura, chest wall, or neuromuscular system. 1 Restrictive lung diseases can be classified as pulmonary parenchyma diseases (intrinsic causes) or extrapulmonary diseases (extrinsic causes ...
2024 GOLD Report Reflects New Research on COPD Management
Dec 8, 2023 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a lead report author and science committee chair for the Global ...
Dupixent Approved as Add-On Maintenance Therapy in COPD
Oct 1, 2024 · The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.. The approval was supported by data from the randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS (ClinicalTrials.gov Identifier ...
A Low Forced Expiratory Flow of 25% to 75% May Indicate Early …
Dec 16, 2022 · Forced expiratory flow between 25% and 75% of vital capacity (FEF 25-75) is likely to identify patients with early evidence of pathologic lung damage in need of careful monitoring and early intervention to prevent additional lung injury, according to study findings published in BMJ Open Respiratory Research.. Traditional spirometric parameters — including forced expiratory volume in 1 second ...
In Bronchiectasis, Cathepsin C Inhibitor Reduces Exacerbation Risk
Sep 25, 2024 · The cathepsin C (CatC) inhibitor BI 1291583 is associated with a decreased risk for an exacerbation in adults with bronchiectasis, according to study findings published in the European Respiratory Journal.. Researchers presented findings from the phase 2 AIRLEAF trial (ClinicalTrials.gov Identifier: NCT05238675), which assessed the efficacy, safety, and optimal dosing of BI 1291583 in adults ...
Donidalorsen Under Review for Hereditary Angioedema
Nov 6, 2024 · The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for donidalorsen for the prophylactic treatment of hereditary angioedema (HAE) in adults and pediatric patients aged 12 years and older.
Diagnosis & Disease Information - Pulmonology Advisor
Apr 5, 2024 · Hemothorax is a collection of blood in the pleural space that is often the result of a traumatic injury. 1 Symptoms of hemothorax include chest pain and shortness of breath. Potential late complications include empyema and fibrothorax, which can lead to lung entrapment or collapse and respiratory failure. 1 Rapid evaluation and diagnosis are crucial for symptom relief and optimal patient outcomes.